Secret Techniques To Improve Pregnancy Testing Market

Manufacturers of pregnancy and fertility rapid tests are providing technologically advanced products that are more sensitive to improve the experience of consumers. For instance, pregnancy rapid tests available 10 years ago were designed to show results at a concentration of above 25IU/L in a sample. The introduction of monoclonal antibody technology for rapid diagnosis improved the sensitivity to 10 IU/L, which enabled the early detection of pregnancy. Manufacturers are also focusing on providing user-friendly and value-added features to customers to differentiate their product offerings. The introduction of digital devices, such as Clearblue Easy, has resulted in the rapid adoption of home pregnancy and fertility test kits. In 2013, Procter & Gamble Co. launched Clearblue fertility, a device equipped with a touchscreen that enables easier input. Fairhaven Health LLC. provides OvaCue, a fertility monitor that can connect to a smartphone app. It helps predict the ovulation time or fertility window, thus improving the chances of conceiving. Therefore, constant technological advancements in pregnancy testing kits are expected to propel the market over the forecast period.

Devices for pregnancy and fertility rapid tests are not covered in most pregnancy coverage policies or health insurance. The cost of pregnancy and fertility rapid test devices is comparatively high in developing regions. A reduction in the cost of devices is likely to boost the adoption of these devices. Considering the high cost of fertility and pregnancy rapid tests in several countries such as Germany, the UK, and others, pregnancy and fertility rapid tests are likely to be covered under reimbursement policies, which is expected to fuel the growth of the pregnancy and fertility test kits market over the forecast period. The Provisional Replacement Certificate (PRC) or European Health Insurance Card (EHIC) entitles individuals to all the benefits that are available in Germany, and which are related to pregnancy or childbirth. Improving reimbursement policies worldwide for pregnancy and fertility testing is expected to boost the demand for pregnancy and fertility test kits over the forecast period.

e.p.t, the first rapid pregnancy test, was launched in the U.S. market over four decades ago when researchers discovered the radioimmunoassay that could detect hCG in urine. In 2003, next-generation rapid test devices based on lateral flow immunoassay were launched in the market. The same technology is being used in the pregnancy and fertility rapid tests that are available at present, which needs to be improved to avoid false positive and false negative results.

Manufacturers of fertility or pregnancy rapid tests can capitalize on this opportunity by launching next-generation rapid tests that can quantitate the hCG levels in the urine to suggest the stage of pregnancy or fertility test, which can help women conceive. For instance, in 2015, Roche launched the anti-Müllerian Hormone Fertility Test that can help assess ovarian reserve. The design of robust methods containing specific antibodies that can selectively detect hCG without interference with LH is likely to present significant growth opportunities for manufacturers.

Manufacturers are providing pregnancy test kits with dual capabilities as well as combined packs of fertility and pregnancy tests, which can be used to qualitatively detect the presence of hCG hormone in urine as well as serum/blood. Users are rapidly adopting these combo kits as they eliminate the necessity to buy separate kits for urine and blood/serum testing. For instance, various products, such as QuickVue hCG Combo, Test & Confirm, ICON 25 hCG, and many others, are available commercially, with the money of buyers, thus providing cost-effective tests.

Women are opting for mid-stream devices over strips and cassettes due to their ease and convenience of use. Cassettes are least preferred by most of the users due to trouble in using droppers to add an accurate quantity of samples to the sample well. Despite the easy availability of strips and dipsticks, most women do not prefer them owing to issues such as erroneous results obtained due to dipping the device for a long time in the sample.

About Us:

DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within less than a year, we have secured more than 100 unique customers from established organizations all over the world.

For more information:

Sai Kiran

Sales Manager at DataM Intelligence

Email: [email protected]

Tel: +1 877 441 4866

Website: www.datamintelligence.com